The relationship between resolution of asymptomatic bacterial vaginosis and spontaneous preterm birth in fetal fibronectin-positive women.
OBJECTIVE
The purpose of this study was to determine the impact of persistent bacterial vaginosis (BV) on the occurrence of spontaneous preterm birth (SPB) in women who test positive for fetal fibronectin.


METHODS
This is a secondary analysis of a subset of pregnant women who tested positive for BV and fetal fibronectin between 16(0/7) and 25(6/7) weeks of gestation and who participated in randomized placebo controlled trials of antibiotic therapy. Nugent's criteria were used for the diagnosis of BV. Patients were reassessed for the presence of BV after treatment. The rate of SPB at <34 weeks of gestation was analyzed on the basis of treatment mode and BV status at the follow-up visit.


RESULTS
The primary studies included a total of 3285 women. A subset of 215 women met the criteria for this analysis. Seventy-seven of 100 patients (77%) in the antibiotics group vs 33 of the 115 patients (28.7%) in the placebo group became BV negative (P < .0001). The rate of SPB at <34 weeks of gestation was lower for BV resolution compared with persistent BV (0 vs 5.7%, respectively; P = .01).


CONCLUSIONS
In women who tested positive for fetal fibronectin and BV, resolution of BV is associated with less SPB before 34 weeks of gestation.
Hendler
Israel
I
Department of Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI 48201, USA. ihendler@med.wayne.edu
Andrews
William W
WW
Carey
Christopher J
CJ
Klebanoff
Mark A
MA
Noble
William D
WD
Sibai
Baha M
BM
Hillier
Sharon L
SL
Dudley
Donald
D
Ernest
Joseph M
JM
Leveno
Kenneth J
KJ
Wapner
Ronald
R
Iams
Jay D
JD
Varner
Michael
M
Moawad
Atef
A
Miodovnik
Menachem
M
O'Sullivan
Mary J
MJ
Van Dorsten
Peter J
PJ
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D015897:Comorbidity; D005260:Female; D005353:Fibronectins / Q000032:analysis; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D011247:Pregnancy; D047928:Premature Birth / Q000453:epidemiology* / Q000517:prevention & control; D016585:Vaginosis, Bacterial / Q000188:drug therapy / Q000453:epidemiology*
D000890:Anti-Infective Agents; D005353:Fibronectins; D008795:Metronidazole